Leading Global Pharmaceutical Company, Teva Pharmaceutical Industries, Transfers Stock Listing to the New York Stock Exchange...
30 Mai 2012 - 7:32PM
Business Wire
Teva Pharmaceutical Industries, a leading global pharmaceutical
company and world’s largest generic drug maker, began trading on
the New York Stock Exchange (NYSE) today under the ticker symbol
“TEVA” after the transfer of its stock listing to the NYSE from
NASDAQ. Dr. Phillip Frost, Chairman of the Board of Directors and
President and CEO Dr. Jeremy M. Levin were joined by Teva’s CFO,
Eyal Desheh; President and CEO of Teva Americas, William S. Marth
and employees from Teva’s businesses around the world to celebrate
the company’s first day of trading on the NYSE by ringing The
Opening BellSM.
Dr. Phillip Frost, Chairman of the Board
of Directors and President and CEO Dr. Jeremy M. Levin, along with
members of Teva Pharmaceutical's management team and employees from
around the globe, ring the NYSE Opening Bell to commemorate Teva's
transfer of its stock listing to the NYSE from NASDAQ. (Photo:
Business Wire)
“Teva is a global pharmaceutical company and a leader in their
industry with a dedication to their patients,” said Diederik
Zandstra, Head of International Listings, NYSE Euronext. “We are
proud that Teva has chosen to transfer to the NYSE and recognizes
the value of our global community, market structure and technology.
We look forward to our partnership with Teva and its
shareholders.”
“We are pleased to partner with the NYSE and begin using their
state of the art trading platform and market research,” stated Dr.
Phillip Frost, Chairman of the Board of Directors of Teva. “We are
joining a network of true innovators and leaders listed on the
NYSE.”
Teva Pharmaceutical is the second largest company to transfer
its stock listing to the NYSE from NASDAQ. Teva is the seventh
company to transfer from NASDAQ to the NYSE in 2012 following
Hercules Technology Growth Capital Inc. (NYSE: HTGC – 4/30/12); TD
Ameritrade Holding Company (NYSE: AMTD – 4/25/12); Arabian American
Development Co. (NYSE: ARSD – 4/2); Halcon Resources Corp (NYSE: HK
– 3/26); Kaman Corporation (NYSE: KAMN – 2/7) and Team Inc. (NYSE:
TISI – 1/3).
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading
global pharmaceutical company, committed to increasing access to
high-quality healthcare by developing, producing and marketing
affordable generic drugs as well as innovative and specialty
pharmaceuticals and active pharmaceutical ingredients.
Headquartered in Israel, Teva is the world's largest generic drug
maker, with a global product portfolio of more than 1,300 molecules
and a direct presence in about 60 countries. Teva's branded
businesses focus on CNS, oncology, pain, respiratory and women's
health therapeutic areas as well as biologics. Teva currently
employs approximately 46,000 people around the world and reached
$18.3 billion in net revenues in 2011. (Source: Teva Pharmaceutical
Industries Ltd.)
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial
markets and provider of innovative trading technologies. The
company's exchanges in Europe and the United States trade equities,
futures, options, fixed-income and exchange-traded products. With
approximately 8,000 listed issues (excluding European Structured
Products), NYSE Euronext's equities markets — the New York Stock
Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca —
represent one-third of the world’s equities trading, the most
liquidity of any global exchange group. NYSE Euronext also operates
NYSE Liffe, one of the leading European derivatives businesses and
the world's second-largest derivatives business by value of
trading. The company offers comprehensive commercial technology,
connectivity and market data products and services through NYSE
Technologies. NYSE Euronext is in the S&P 500 index. For more
information, please visit: http://www.nyx.com.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50294199&lang=en
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024